Santiago Arroyo

Director/Board Member bij H. LUNDBECK A/S

Vermogen: 971 100 $ op 31-03-2024

64 jaar

Connecties 100

Health Technology

Consumer Services

Health Services

Momenteel actieve connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Michael Skynner	M	55	BICYCLE THERAPEUTICS PLC PFIZER, INC.	11 jaar
Kevin Lee	M	55	BICYCLE THERAPEUTICS PLC PFIZER, INC.	12 jaar
Ganesh Venkataraman Kaundinya	M	57	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	4 jaar
Amir Faridmoayer	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Jose-Carlos Gutiérrez-Ramos	M	61	BICYCLE THERAPEUTICS PLC PFIZER, INC.	9 jaar
Dominique Sirena	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Alistair Milnes	M	50	BICYCLE THERAPEUTICS PLC	3 jaar
Lars Søren Rasmussen	M	65	H. LUNDBECK A/S	11 jaar
Jim Smith	M	64	PFIZER, INC.	10 jaar
Stephen Sands	M	67	BICYCLE THERAPEUTICS PLC	-
Jeremy Levin	M	70	H. LUNDBECK A/S	7 jaar
Jeffrey Berkowitz	M	58	H. LUNDBECK A/S	6 jaar
Gregory Winter	M	73	BICYCLE THERAPEUTICS PLC	15 jaar
Lene Skole-Sørensen	F	65	H. LUNDBECK A/S	9 jaar
Helen Hobbs	M	71	PFIZER, INC.	13 jaar
Joseph Echevarria	M	66	PFIZER, INC.	9 jaar
Janice Bourque	F	67	BICYCLE THERAPEUTICS PLC	5 jaar
Travis Thompson	M	-	BICYCLE THERAPEUTICS PLC	6 jaar
Dorothea Wenzel	M	55	H. LUNDBECK A/S	3 jaar
Lars Erik Holmqvist	M	64	H. LUNDBECK A/S	9 jaar
Richard Kender	M	68	BICYCLE THERAPEUTICS PLC	5 jaar
Shantanu Narayen	M	60	PFIZER, INC.	11 jaar
Lars Bang	M	61	H. LUNDBECK A/S	36 jaar
Charl van Zyl	M	57	H. LUNDBECK A/S	1 jaar
Lasse Skibsbye	M	41	H. LUNDBECK A/S	2 jaar
Denis Patrick	M	-	PFIZER, INC.	14 jaar
Zafar Qadir	M	-	BICYCLE THERAPEUTICS PLC	4 jaar
Sonya Weigle	F	-	MARINUS PHARMACEUTICALS, INC.	3 jaar
Thomas Edward Gibbs	M	53	H. LUNDBECK A/S	1 jaar
Tarek Samad	M	-	H. LUNDBECK A/S	3 jaar
Steve Danehy	M	-	PFIZER, INC.	12 jaar
Dorte Clausen	F	40	H. LUNDBECK A/S	2 jaar
Hossein Armandi	M	62	H. LUNDBECK A/S	2 jaar
Camilla Andersson	F	52	H. LUNDBECK A/S	2 jaar
Nicholas Keen	M	56	BICYCLE THERAPEUTICS PLC	7 jaar
Thomas Mikkel Mortensen	M	-	H. LUNDBECK A/S	-
Georges Gemayel	M	64	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 jaar
Keld Flintholm Jørgensen	M	53	H. LUNDBECK A/S	5 jaar
Monique Schiersing	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
David Borah	M	-	BICYCLE THERAPEUTICS PLC	3 jaar
James Sutcliffe	M	68	BICYCLE THERAPEUTICS PLC	1 jaar
Pierre Legault	M	63	BICYCLE THERAPEUTICS PLC	5 jaar
Palle Holm Olesen	M	-	H. LUNDBECK A/S	-
Graziano Seghezzi	M	55	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Nigel Crockett	M	59	BICYCLE THERAPEUTICS PLC	5 jaar
Kush Parmar	M	42	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 jaar
Johan Luthman	M	65	H. LUNDBECK A/S	5 jaar
Alethia Young	F	45	BICYCLE THERAPEUTICS PLC	1 jaar
Jakob Riis	M	58	H. LUNDBECK A/S	1 jaar
Juliane Lenzner	F	-	H. LUNDBECK A/S	-
Ivan Cheung	M	47	EISAI CO., LTD.	19 jaar
Jörg Hornstein	M	47	H. LUNDBECK A/S	2 jaar
Mira Chaurushiya	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Philippe Dro	M	61	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 jaar
Jennifer Perry	F	-	BICYCLE THERAPEUTICS PLC	-

Meer zien

Relatiegrafiek

Connectie in verschillende bedrijven

Oude connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Jeffrey Kindler	M	68	PFIZER, INC.	8 jaar
William Steere	M	87	PFIZER, INC.	28 jaar
Lee Kalowski	M	43	BICYCLE THERAPEUTICS PLC	6 jaar
Deborah Dunsire	M	61	H. LUNDBECK A/S	5 jaar
Amy Schulman	F	63	PFIZER, INC.	6 jaar
George A. Lorch	M	82	PFIZER, INC.	15 jaar
Michael Dougherty	M	66	MARINUS PHARMACEUTICALS, INC.	5 jaar
Yi Ning Zhao	M	53	PFIZER, INC.	8 jaar
Elise Hauge	F	57	H. LUNDBECK A/S	4 jaar
John Mascotte	M	84	PFIZER, INC.	4 jaar
Shinji Hatta	M	-	EISAI CO., LTD.	4 jaar
Marc Tessier-Lavigne	M	64	PFIZER, INC.	4 jaar
Jacob Tolstrup	M	52	H. LUNDBECK A/S	25 jaar
Anders Götzsche	M	56	H. LUNDBECK A/S	15 jaar
Everett Cunningham	M	57	PFIZER, INC.	9 jaar
Robert Landry	M	60	PFIZER, INC.	4 jaar
Olivier Brandicourt	M	68	PFIZER, INC.	13 jaar
Nicole Vitullo	F	66	MARINUS PHARMACEUTICALS, INC.	17 jaar
Veronica Jordan	M	73	BICYCLE THERAPEUTICS PLC	5 jaar
Michael Brown	M	82	PFIZER, INC.	16 jaar
M. Anthony Burns	M	81	PFIZER, INC.	25 jaar
William Herbert Gray	M	82	PFIZER, INC.	13 jaar
Robert N. Burt	M	86	PFIZER, INC.	11 jaar
Alan Mendelsohn	M	62	PFIZER, INC.	2 jaar
David Peritt	M	60	PFIZER, INC.	1 jaar
Paulash Mohsen	M	-	PFIZER, INC.	14 jaar
Premal Patel	M	54	PFIZER, INC.	2 jaar
Margaret Marshall	M	67	PFIZER, INC.	8 jaar
Venkat Reddy	M	-	PFIZER, INC.	2 jaar
Reina Benabou	M	60	PFIZER, INC.	4 jaar
Bhooshitha B. de Silva	M	49	PFIZER, INC.	11 jaar
Tanya de Foras	F	53	PFIZER, INC.	10 jaar
Hong I. Wan	M	-	PFIZER, INC.	5 jaar
Carl Morris	M	54	PFIZER, INC.	5 jaar
Soma Gupta	F	-	PFIZER, INC.	6 jaar
Adrian Woolfson	M	60	PFIZER, INC.	3 jaar
William S. Korinek	M	-	PFIZER, INC.	9 jaar
Baiyong Li	M	56	PFIZER, INC.	12 jaar
Margaret McLoughlin	M	61	PFIZER, INC.	5 jaar
Santhosh Palani	M	41	PFIZER, INC.	3 jaar
Valerie Start	M	64	PFIZER, INC.	3 jaar
Karen Boykin-Towns	F	59	PFIZER, INC.	4 jaar
Nat Ricciardi	M	75	PFIZER, INC.	7 jaar
Martine George	M	76	PFIZER, INC.	5 jaar
Iain Kilty	M	-	PFIZER, INC.	6 jaar

Statistieken

Land	Connecties	% van het totaal
Verenigde Staten	48	48.00%
Denemarken	25	25.00%
Verenigd Koninkrijk	19	19.00%
Zwitserland	9	9.00%
Japan	2	2.00%

Ouderdom van de connecties

Actief

Verleden

Man

Vrouw

Besturend

Uitvoerend

Oorsprong van de connecties

Beurs
Insiders
Santiago Arroyo
Persoonlijk netwerk